Actual Medicinal Product (AMP) Prucalopride 1mg tablets (Accord-UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability

Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

The SPC states store in the original container to protect from moisture.

Provenance

This compatibility recommendation is derived from Resolor 1mg tablets (Takeda UK Ltd).

Generic

Prucalopride

Formulation

Prucalopride 1mg tablets

Alternative Suppliers (17)

Resolor 1mg tablets (Takeda UK Ltd)

Resolor 1mg tablets (CST Pharma Ltd)

Prucalopride 1mg tablets (Dexcel-Pharma Ltd)

Prucalopride 1mg tablets (Alliance Healthcare (Distribution) Ltd)

Prucalopride 1mg tablets (Macleods Pharma UK Ltd)

Prucalopride 1mg tablets (A A H Pharmaceuticals Ltd)

Prucalopride 1mg tablets (Axunio Ltd)

Prucalopride 1mg tablets (DE Pharmaceuticals)

Prucalopride 1mg tablets (Zentiva Pharma UK Ltd)

Prucalopride 1mg tablets (Morningside Healthcare Ltd)

Prucalopride 1mg tablets (Thornton & Ross Ltd)

Prucalopride 1mg tablets (Cipla EU Ltd)

Prucalopride 1mg tablets (Aristo Pharma Ltd)

Prucalopride 1mg tablets (DHP Healthcare Ltd)

Prucalopride 1mg tablets (Accord-UK Ltd)

Prucalopride 1mg tablets (Torrent Pharma (UK) Ltd)

Prucalopride 1mg tablets (Amarox Ltd)

Related Formulations (2)

Prucalopride 1mg tablets

Prucalopride 2mg tablets